Surgery Doctors in Beavercreek, OH Accepting Medicare

6 Surgery doctors found. Showing 1 - 6

Dr. Alberto Jose Lopez, M.D. Surgery - Vascular Surgery Medicare: Accepting Medicare Assignments Practice Location: 4447 Somerset Path, Beavercreek, OH 45440 Phone: 216-965-7384

Brian W Ondulick, DO Surgery Medicare: Accepting Medicare Assignments Practice Location: 3535 Pentagon Blvd, Suite 320, Beavercreek, OH 45431 Phone: 937-490-2270    Fax: 937-490-2272

Christopher Robert Schneider, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 725 University Blvd, Beavercreek, OH 45324 Phone: 937-245-7900

Dr. Wesley Javeed Johnson, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 3535 Pentagon Blvd Ste 320, Beavercreek, OH 45431 Phone: 937-490-2270    Fax: 937-490-2272

Alyssa Jennifer Gans, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 3535 Pentagon Blvd Ste 330, Beavercreek, OH 45431 Phone: 937-395-8556    Fax: 937-395-6376

Dr. Jacob Carmen Yannetta Iii, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2141 N Fairfield Rd, Ste. B, Beavercreek, OH 45431 Phone: 937-458-0025    Fax: 937-458-0212

News Archive

CSL362 antibody targets, depletes pDCs and other cells implicated in SLE

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that affects multiple organ systems. Autoantibodies, which are produced by B cells, contribute to development of SLE.

Researchers find that hay fever and allergies make migraines worse

People with migraine who also battle allergies and hay fever (rhinitis) endure a more severe form of headaches than their peers who struggle with migraine, but aren't affected by the seasonal or year-round sniffles, according to researchers from the University of Cincinnati, Montefiore Medical Center and the Albert Einstein College of Medicine of Yeshiva University and Vedanta Research.

FDA approves change to prescribing information for Gilead Sciences' Letairis

Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration has approved a change to the prescribing information for Letairis (ambrisentan 5 mg and 10 mg tablets), the company's once-daily treatment to improve exercise ability and delay clinical worsening in pulmonary arterial hypertension (PAH, WHO Group 1) patients with predominantly WHO Functional Class II-III symptoms.

Transitional care can improve health outcomes, reduce hospital readmissions

Currently, one in five elderly patients discharged from a hospital is readmitted within a month. Seeking to address the human and substantial financial burden of revolving door hospital readmissions, the Affordable Care Act proposes a number of initiatives to improve care and health outcomes and reduce costs for the growing population of chronically ill people in the U.S. While transitional care is a central theme in these provisions, there is little information available to guide those responsible for implementing these important opportunities.

Read more Medical News

› Verified 8 days ago